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Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) and other cyclic nitroxides have been shown
to inhibit the chlorinating activity of myeloperoxidase (MPO) in vitro and in cells. To examine whether
nitroxides inhibit MPO activity in vivo we selected acute carrageenan-induced inﬂammation on the rat
paw as a model. Tempol and three more hydrophobic 4-substituted derivatives (4-azido, 4-benzene-
sulfonyl, and 4-(4-phenyl-1H-1,2,3-triazol-1-yl)) were synthesized, and their ability to inhibit the
in vitro chlorinating activity of MPO and carrageenan-induced inﬂammation in rat paws was evaluated.
All of the tested nitroxides inhibited the chlorinating activity of MPO in vitro with similar IC50 values
(between 1.5 and 1.8 mM). In vivo, the attenuation of carrageenan-induced inﬂammation showed some
correlation with the lipophilicity of the nitroxide at early time points but the differences in the effects
were small (o2-fold) compared with the differences in lipophilicity (4200-fold). No inhibition of MPO
activity in vivo was evident because the levels of MPO activity in rat paws correlated with the levels of
MPO protein. Likewise, paw edema, levels of nitrated and oxidized proteins, and levels of plasma
exudation correlated with the levels of MPO protein in the paws of the animals that were untreated or
treated with the nitroxides. The effects of the nitroxides in vivo were compared with those of 4-
aminobenzoic hydrazide and of colchicine. Taken together, the results indicate that nitroxides
attenuate carrageenan-induced inﬂammation mainly by reducing neutrophil migration and the
resulting MPO-mediated damage. Accordingly, tempol was shown to inhibit rat neutrophil migration
in vitro.
& 2012 Elsevier Inc. Open access under the Elsevier OA license.Nitroxides are stable free radicals that are receiving increased
attention as potential therapeutic agents because of their pronounced
antioxidant properties and their low toxicity [1–6]. In vivo, the most
investigated nitroxide is tempol1 (4-hydroxy-2,2,6,6-tetramethyl
piperidine-1-oxyl), which has been shown to effectively reduce tissue
injury in animal models of inﬂammation [7]. The mechanisms of
protection are not completely understood but have been attributed
mainly to the ability of nitroxides (TPNO) to act as nearly catalytic1
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myristate acetate; tempol,
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lsevier OA license.multifunctional antioxidants in vivo. Indeed, nitroxides react with
diverse biological oxidants and reductants while being recycled
through the oxammonium cation (TPNOþ) and hydroxylamine
derivatives (TPNOH). After several redox cycles, nitroxides are even-
tually consumed by recombination reactions with speciﬁc radicals,
such as tyrosyl (P(OH)) and thiyl (RS) radicals, and/or by metabo-
lism [3–6]. More recently, the ability of nitroxides to modulate
enzymatic activities has been described. For example, tempol has
been shown to downregulate the expression of inducible nitric oxide
synthase during cutaneous Leishmania infection [8]. Additionally,
nitroxides have been shown to inhibit the chlorinating activity of
myeloperoxidase (MPO) in vitro and in activated neutrophils [9,10].
The therapeutic potential of nitroxides justiﬁes further study of their
properties as antioxidants and enzyme modulators in animal models
[1,3,8–12].
We reasoned that acute carrageenan-induced inﬂammation in
the rat paw [13,14] was likely to provide new information about
Scheme 1. Structure of tempol and the 4-substituted derivatives synthesized and
tested in this study.
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mediated damage in vivo. This animal model is well established
and has been extensively used for testing anti-inﬂammatory
drugs. The signs of inﬂammation, such as edema, hyperalgesia,
and erythema, develop immediately after intramuscular injection
of carrageenan, resulting from the action of proinﬂammatory
mediators, such as bradykinin, histamine, complement, and oxy-
gen- and nitrogen-derived reactive species. These mediators can
be generated in situ at the site of insult and by inﬁltrating cells.
Rapid migration and degranulation of neutrophils provide high
MPO contents at the inﬂammation sites. Previously, tempol has
been shown to attenuate carrageenan-induced paw edema and
hyperalgesia, but the relevant study was mainly phenomenologi-
cal [15]. A more mechanistic study described the attenuating
effects of tempol in carrageenan-induced pleurisy [16], but the
role of MPO in the process was not speciﬁcally addressed.
In this work, tempol and three 4-substituted nitroxide deriva-
tives were synthesized (Scheme 1), and their ability to inhibit the
in vitro chlorinating activity of MPO and carrageenan-induced
inﬂammation in rat paws was evaluated. Although tempol dis-
tributes well in organs and tissues, a comparison of its effects
with a series of nitroxide analogs bearing various hydrophobic
functional groups at the C-4 position of the piperidinyl ring
in vitro and in vivo could provide some insight on structure–
activity relationships. In particular, the tempol–triazole conjugate
(tritempo) seemed interesting to us because of the many phar-
macological actions of the azole moiety [17,18].Experimental procedures
Materials
All of the chemicals were purchased from Sigma–Aldrich, Merck,
or Fisher, unless stated otherwise, and were analytical grade or better.
ABAH (4-aminobenzoic hydrazide) was from Sigma. MPO from
human leukocytes was obtained from Alexis Biochemicals (purity
index A430/A280¼0.65). The MPO concentration was determined
spectrophotometrically (e430¼8.9104 M1 cm1 per heme) [19].
Hypochlorous acid was distilled from a commercial solution and kept
at 80 1C until use. Stock solutions of hypochlorous acid were
prepared immediately before use, and the concentrations weredetermined spectrophotometrically (e290¼3.5102 M1 cm1) [20].
The solutions of hydrogen peroxidewere prepared before use, and the
concentrations were determined spectrophotometrically by reaction
with horseradish peroxidase to produce compound I (De403¼
5.5104 M1 cm1) [21]. Tempol concentration was determined
spectrophotometrically (e240¼1.44103 M1 cm1) [22]; concen-
trations of the other nitroxides were determined by electron para-
magnetic resonance (EPR) by a comparison with known con-
centrations of tempol. Anti-MPO, anti-3-nitrotyrosine, and anti-
methionine sulfoxide were obtained from Abcam, Oxis, and Oxford
Biomedical Research, respectively. Rabbit anti-sheep IgG was pur-
chased from Calbiochem and goat anti-rabbit IgG was purchased
from Sigma. EDTA-free protease inhibitor cocktail was obtained from
Roche Applied Science. Fluorescein-5-thiosemicarbazide (FTC) was
purchased from Molecular Probes. All of the solutions were prepared
with water puriﬁed in a Millipore Milli-Q system. All of the buffers
were treated with Chelex-100 to remove trace amounts of metal ion
contaminants before use.Nitroxide synthesis
The compounds tempol, 4-benzenesulfonyl-2,2,6,6-tetra-
methylpiperidine-1-oxyl (bztempo), and 4-azido-2,2,6,6-tetra-
methylpiperidine-1-oxyl (N3tempo) (Scheme 1) were prepared
according to the synthetic pathways described in the literature
[23,24]. The novel nitroxide 4-(4-phenyl-1H-1,2,3-triazol-1-yl)-2,
2,6,6-tetramethylpiperidine-1-oxyl) (tritempo) was obtained in
good yield by the [3 þ 2] cycloaddition reaction between
N3tempo and phenylacethylene (Supplementary Scheme S1)
[25]. All the synthetic and characterization procedures are fully
described in the Supplementary material.Determination of the partition coefﬁcient values
The log P values were determined by a reverse-phase HPLC
procedure [26–28]. The employed column was a 1-octanol-coated
ODS-Hypersil guard column (204 mm; mean particle size
3 mm). The mobile phase was 1-octanol saturated with distilled
water. All of the measurements were made in triplicate at room
temperature (2571 1C). The log P values were calculated from
the HPLC capacity factor (log k0) deﬁned by the expression
k0 ¼(trt0)/t0, where t0 is the dead time measured by thiourea
injection and tr is the retention time of the analyzed nitroxide
(approximately 1 ml of an aqueous solution was injected). The
linear equation relating log k0 to log P (log P¼1.061 log k0 þ0.403
(R2¼0.9886)) was obtained by least-squares linear regression of
the determined k0 values for standard compounds with known log
P values; in other words, benzamide (log P¼0.64), acetanilide (log
P¼1.00), acetophenone (log P¼1.70), nitrobenzene (log P¼1.85),
and para-chlorophenol (log P ¼2.40) [28].MPO-chlorinating activity in vitro
The reaction mixtures contained MPO (15 nM per heme),
hydrogen peroxide (50 mM), chloride (100 mM), taurine
(15 mM), and nitroxides (at the speciﬁed concentrations) in
50 mM phosphate buffer, pH 7.4. The reactions were incubated
at 37 1C, and the chlorinating activity was monitored by taurine
chloramine formation. The reactions were started by the addition
of hydrogen peroxide (50 mM). Aliquots were removed at various
times and the reaction was stopped by the addition of 100 mg/ml
catalase. Taurine chloramine formation was quantiﬁed spectro-
photometrically after reaction with 2-nitro-5-thiobenzoic acid
(e412¼1.41104 M1 cm1) [29].
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Male Wistar rats (200–250 g; 7–8 weeks of age) were obtained
from our animal facilities, and experiments were performed
following the animal guidelines of the Committee of Animal
Ethics of Instituto de Quı´mica, Universidade de S~ao Paulo, under
Certiﬁcates 03/2007 and 11/2011. Nitroxides (0.17 mmol/kg),
indomethacin (10 mg/kg), colchicine (2 mg/kg), ABAH (60 mg/kg),
or vehicle (dimethyl sulfoxide (DMSO), 200 ml) was injected ip
15 min before carrageenan intraplantar injection (100 ml of 1% l-
carrageenan, type IV; Sigma; diluted in saline) in the left hindfoot
pad [13,14]. The paw thickness was measured before and 1.5, 3.0,
4.5, and 6.0 h after carrageenan administration using a vernier
caliper. Three or 6 h after carrageenan administration, the animals
were euthanized with a lethal dose of xylazine and ketamine. The
paw muscle was removed, washed twice in saline, ﬂash-frozen in
liquid nitrogen, and kept at 80 1C until processing.Preparation of tissue extracts
For the analysis of 3-nitrotyrosine, methionine sulfoxide,
chlorotyrosine, carbonylated proteins, and nitroxides, the homo-
genates were prepared as previously described with minor
modiﬁcations [8]. Frozen tissues were pulverized in liquid nitro-
gen using a mortar and pestle and homogenized in 5 vol of ice-
cold lysis buffer (50 mM phosphate buffer, 5 mM diethylenetria-
minepentaacetic acid (DTPA), 1% Triton X-100 v/v, 1 vol of EDTA-
free protease inhibitor cocktail, 50 mM methionine, pH 7.4) with
a tissue homogenizer (Ultra-Turrax T8) in an ice bath. The
homogenates were centrifuged (1000g) for 10 min at 4 1C, and
the supernatants were collected. Protein levels were determined
using the Bradford assay (Bio-Rad kit), and the samples were kept
at 80 1C until further analysis. For analysis of MPO protein and
activities, the homogenates were prepared as previously
described with minor modiﬁcations [30] The pulverized tissue
was homogenized as described above in 5 vol of 50 mM buffer
phosphate (pH 7.4) containing 0.5% hexadecyltrimethylammo-
nium bromide. After centrifugation (12,000g) for 30 min at 4 1C,
the supernatants were collected and protein levels were deter-
mined by the Bradford assay (Bio-Rad kit). The samples were kept
at 80 1C until further analysis.Analysis of proteins containing nitrated and methionine sulfoxide
residues by dot blot
Homogenates (5 mg of protein) were transferred onto a nitro-
cellulose membrane through a dot-blot system (Bio Rad) and the
membrane was blocked with 5% nonfat dried milk (2 h) before
exposure to primary antibody solution for 2 h (sheep monoclonal
anti-nitrotyrosine, 1:5000; Abcam) or overnight (rabbit anti-
methionine sulfoxide, 1:1000; Oxford Medical Research). The
primary antibodies were revealed by 1 h incubation with second-
ary antibodies labeled with horseradish peroxidase (rabbit anti-
sheep IgG, 1:5000, Calbiochem; and goat anti-rabbit IgG, 1:2500,
Sigma; respectively). Densitometry analysis was performed with
the ImageJ 1.44p software (NIH, Bethesda, MD, USA). Levels of 3-
nitrotyrosine residues were estimated by comparison with those
of bovine serum albumin (BSA) nitrated by peroxynitrite, the 3-
nitrotyrosine content of which was determined by the absorbance
at 430 nm at pH 412 (e430nm¼4.4103 M1 cm1) [31].
Methionine sulfoxide content was normalized as percentage of
carrageenan control. The contents of the blotted proteins were
determined by Ponceau S staining [32].Analysis of 3-chlorotyrosine residues by liquid chromatography/
electrospray ionization/mass spectrometry (LC/ESI/MS) with stable
isotope dilution
Homogenates (1 mg of protein) were precipitated by addition
of 10-fold excess of cold acetone (20 1C) and kept overnight at
20 1C. After centrifugation at 16,000g for 10 min at 4 1C, protein
pellets were broken up and delipidated twice with water:metha-
nol:ethylic ether (1:3:7 v/v/v) [33]. Next, the samples were
treated with a solution of 30 mM dithiothreitol in 6 M guanidine
hydrochloride and 50 mM Tris–HCl, pH 8, under a reduced oxygen
atmosphere for 2 h at 37 1C. Then, the samples were treated with
a freshly prepared 150 mM iodoacetic acid solution whose pH
was adjusted to 8. After incubation for 2 h at 37 1C in the dark, the
sample was passed through a PD-10 column and dried. The dried
samples were resuspended in 50 mM ammonium bicarbonate
buffer, pH 7.8, containing 1.2 mg Pronase, 10 mM calcium chlor-
ide, and 100 pmol 3-chloro[13C6]tyrosine (Cambridge Isotope
Laboratories) and incubated at 40 1C for 12 h. After addition of
more Pronase (1.2 mg) and calcium chloride (10 mM), the sample
was incubated at 40 1C for a further 12 h [34]. The digested
samples were dried, resuspended in 100 ml of formic acid 0.1%,
and ﬁltered through a 0.22-mm Millipore ﬁlter. Tyrosine and 3-
chlorotyrosine were analyzed by LC/MS in a Shimadzu ultraper-
formance liquid chromatography instrument interfaced with a
mass spectrometer (Bruker UHR-ESI-qTOF Maxis 3G) [35]. Chro-
matographic separation was performed with a C-18 Gemini
column (2504.60 mm, particle size 5 mm) employing a binary
gradient using 0.1% formic acid as eluent A and 0.1% formic acid in
acetonitrile as eluent B. The linear gradient was 0–10% B over
30 min, 10–50% B over 10 min, 50–0% B over 50 min, and 0% B
over 10 min; the ﬂow rate was 0.6 ml/min. A ﬂow divider of
150 ml/min was coupled between the chromatograph and the
mass spectrometer. The ions used for detecting the analytes and
the internal standards were tyrosine (m/z 180), 3-chlorotyrosine
(m/z 216), and 3-chloro[13C6]tyrosine (m/z 222). The limit of
detection (signal/noise 45) was Z100 pmol. The operating
conditions of the mass spectrometer were capillary voltage of
4200 V, cone voltage of 500 V, nebulizing gas at 1.6 bar, drying
gas at 8.0 L/min. The data were analyzed using Compass Data
Analysis software (microTOF Control).
Analysis of carbonylated proteins by labeling with FTC
The level of carbonylated proteins was determined as pre-
viously described [36], with minor modiﬁcations. Homogenates
(100 ml at 1 mg/ml protein) were incubated with 1 mM FTC in
50 mM phosphate buffer, pH 6.0, for 2 h at 37 1C in the dark.
Proteins were then precipitated by the addition of a 10-fold
excess of cold acetone (20 1C) and kept overnight at 20 1C.
After 10 min centrifugation (16,000g) at 4 1C, the pellets were
broken up and washed twice with acetone. Protein pellets were
resuspended in Laemmli buffer and 50 mg was subjected to 12%
SDS–PAGE [37]. A ﬂuorescent protein image from the gel was
captured with the Typhoon Trio using an excitation wavelength of
488 nm and an emission ﬁlter at 520 nm (40 nm bandpass).
Relative quantiﬁcation of the lanes (from top to bottom) was
performed with the ImageJ 1.44p software (NIH). Then, the gels
were ﬁxed with 50% methanol and 10% acetic acid for 10 min
followed by staining overnight with Coomassie blue. Densitometry
analysis was performed as above.
Analysis of nitroxides and their hydroxylamine derivatives by EPR
EPR spectra were recorded at room temperature on a Bruker
ER 200 D-SRC upgraded to an EMX instrument. Paw muscle
R.F. Queiroz et al. / Free Radical Biology and Medicine 53 (2012) 1942–1953 1945homogenates containing 500 mg of protein were subjected to EPR
analysis before (to determine nitroxide levels) and after the
addition of 1 mM potassium ferricyanide (to determine nitroxide
plus hydroxylamine levels) [8]. Nitroxide concentration in the
homogenates was estimated by a double integration of the EPR
spectrum and a comparison with that of a standard tempol
solution scanned under the same conditions.
Peroxidase activity in rat paw homogenates
Hydrogen peroxide (50 mM) was added to incubations contain-
ing paw muscle homogenates (10 mg, 200 ml), tetramethylbenzi-
dine (TMB; 1.4 mM), and dimethylformamide (8%) in acetate
buffer (50 mM), pH 5.4, and TMB oxidation was monitored at
655 nm (e655nm¼3.9104 M1 cm1) [29]. One unit of peroxi-
dase was deﬁned as the amount of enzyme that forms 1 mmol of
TMB oxidized per minute. The results were expressed as speciﬁc
activity (U/mg protein).
Chlorinating activity in rat paw homogenates
Hydrogen peroxide (50 mM) was added to incubations contain-
ing paw muscle homogenates (50 mg, 200 ml), chloride (100 mM),
and taurine (15 mM) in phosphate buffer (50 mM), pH 7.4. After
5 min incubation at 37 1C, the taurine chloramine formation was
quantiﬁed by reaction with 2-nitro-5-thiobenzoic acid [29]. One
unit of MPO was deﬁned as the amount of enzyme that forms
1 mmol of taurine chloramine per minute. The results were
expressed as the speciﬁc activity (U/mg protein).
Immunodetection of MPO levels in paw muscle homogenates
Homogenates (100 mg of protein) were subjected to electro-
phoresis (12% SDS–PAGE) and were transferred to nitrocellulose
membranes (GE Healthcare) using a Bio-Rad semidry transfer
system according to the manufacturer’s instruction. The blocking
was carried out with 3% BSA in Tris-buffered saline with 0.05%
Tween overnight. Immunodetection was performed with
enhanced chemiluminescence (Pierce SuperSignal West Pico)
[38] using rabbit anti-MPO antiserum (1:2000, overnight) as the
primary antibody and goat anti-rabbit IgG as the secondary
antibody. Image analysis was performed as described above, and
MPO levels were determined by a comparison with a known
amount of human MPO. The detection limit of the anti-MPO
antiserum was approximately 30 ng of human MPO. Membranes
were subsequently stripped using Tris buffer (50 mM) containing
SDS (2%) and b-mercaptoethanol (100 mM), at pH 6.8, and were
reprobed with rabbit anti-actin serum (1:3000, 2 h). The densi-
tometry for each lane was calculated using ImageJ 1.44p (NIH)
software.
Characterization of the main carbonylation target by two-
dimensional (2D) electrophoresis and matrix-assisted laser
desorption/ionization quantitative time-of-ﬂight (MALDI Q-TOF)
analysis
Paw muscle homogenates (1 mg/ml protein, 100 ml) from rats
treated or not with carrageenan for 3 h were labeled with FTC as
described above, and the FTC-labeled proteins were then resolved
using 2D gel electrophoresis, as previously described [39]. Brieﬂy,
the ﬁnal washed FTC-labeled pellets were dissolved in rehydra-
tion buffer containing urea (7 M), thiourea (2 M), Chaps (2%), IPG
(1%), and bromophenol blue (0.002%) and were incubated at 37 1C
for 5 min followed by ultrasonic treatment (three times for
3 min). After centrifugation (16,000g for 2 min), the supernatant
(70 mg protein) was applied to nonlinear 7-cm Imobiline drystrips (GE Healthcare), pH 3–10. After focusing, the proteins were
separated in the second dimension by electrophoresis (12% SDS–
PAGE). The gels were scanned using the Typhoon Trio variable
mode imager with an excitation wavelength of 488 nm and an
emission ﬁlter at 520 nm (40 nm bandpass). The image was
captured in a digital format, and the data were imported into
ImageQuant 5.0. After the ﬂuorescence from FTC in the proteins
was measured, the gels were ﬁxed with 50% methanol and 10%
acetic acid for 10 min followed by staining overnight with the
colloidal Coomassie blue. The stained gels were washed in 10%
acetic acid several times to remove residual dye from the poly-
acrylamide matrix; they were placed in water and scanned for
protein content. The main protein spot was manually excised
from the Coomassie-stained gel and in-gel digested with trypsin,
as previously described [40]. The gel spot was treated with
10 mM dithiothreitol and then alkylated with 50 mM iodoaceta-
mide followed by three washing steps with 180 ml of 50%
acetonitrile and 50 mM ammonium bicarbonate for 15 min,
followed by one washing step with 180 ml of acetonitrile for
15 min. After being washed, the gel spot was dried by vacuum
centrifugation and was subjected to trypsin digestion for 18 h at
37 1C using 40 ml of 10 ng/ml modiﬁed porcine trypsin (sequen-
cing-grade modiﬁed trypsin; Promega) diluted in 50 mM ammo-
nium bicarbonate. After digestion, peptides were extracted by
two elution steps using 30 ml of 5% formic acid followed by
extraction with 30 ml of 5% formic acid (50% acetonitrile) for
30 min each step. Extracted peptides were dried up to 1 ml. The
peptides were analyzed by MALDI Q-TOF MS/MS in a Waters
Micromass Q-TOF Premier mass spectrometer equipped with a
MALDI source (MALDI Q-TOF; Waters Corp.) at the Brazilian
Synchrotron Light Laboratory (Campinas, SP, Brazil). The peptide
masses were entered into Mascot (www.matrixscience.com/), and
the SwissProt database was searched to identify the protein.
Assay of rat neutrophil chemotaxis in vitro
Neutrophils were obtained and puriﬁed as previously described
[41] with adaptations to the rat model. Brieﬂy, sodium caseinate
(1.5 mg/kg, saline) was injected ip into male Wistar rats (8 weeks,
200–250 g). After 3 h, the animals were sacriﬁced in a carbon dioxide
chamber and peritoneal cells harvested with 6.0 ml of ice-cold
phosphate-buffered saline (PBS). Cell suspensions were pelleted by
centrifugation (250g, for 10 min) and resuspended in 1.0 ml of PBS–
glucose and the number of cells was determined by counting in a
Neubauer chamber. The cell population obtained was constituted
mainly of polymorphonuclear leukocytes (95%). Rat neutrophils
(3.3106/ml) were preincubated with various concentrations of
tempol in RPMI (BSA 0.1%) for 30 min at 37 1C. Next, the migratory
assay was performed using a modiﬁed Boyden chamber [42]. The
preincubated cell suspensions (1.5106 neutrophils) were added to
the upper compartment of the chamber separated by a cellulose
nitrate ﬁlter (8-mm average pore size) from the lower compartment,
which contained PMA (100 ng/ml) in RPMI (BSA 0.1%) or RPMI (BSA
0.1%) only for the controls (random migration) [43]. The cells were
incubated for 2 h at 37 1C under humidiﬁed air with CO2 (5%),
followed by removal of the ﬁlters for cell ﬁxation and staining with
Harris’s hematoxylin. Neutrophil migration within the ﬁlter was
determined under light microscopy by the ‘‘leading front’’ method,
in which the distance was measured from the top of the ﬁlter to the
farthest plane still containing two cells with a 40 objective. Four
ﬁelds were counted and averaged for each ﬁlter.
Statistical analysis
All of the data are expressed as the mean7standard deviation.
Statistical signiﬁcance was calculated with a one-tailed t test or,
Fig. 1. Inhibition of MPO-mediated taurine chlorination by nitroxides. The reactions contained MPO (15 nM), hydrogen peroxide (50 mM), taurine (15 mM), sodium
chloride (100 mM), DTPA (0.1 mM), and the speciﬁed concentrations of (A) N3tempo, (B) bztempo, or (C) tritempo in phosphate buffer (50 mM), pH 7.4. The percentage of
inhibition of taurine chloramine formation by the speciﬁed nitroxide concentration compared with the control (in the absence of nitroxide) is plotted after 5 (open bars),
15 (black bars), and 30 min (gray bars) of incubation. All of the incubations were performed at 37 1C. In (D), the data obtained for tritempo (C) after 15 min of incubation
were replotted to calculate the IC50 value, which was determined by ﬁtting a rectangular hyperbola to the dose–response curve using nonlinear regression. The values
shown are the mean7standard deviation values obtained in three independent experiments; *p o 0.01 and **p o 0.05, one-way ANOVA with a Tukey posttest for
multiple comparisons.
Table 1
IC50 values for the inhibition of the chlorinating activity of MPO and lipophilicity
coefﬁcients of the studied nitroxides.
Nitroxide Log Pa IC50
b (mM)
R.F. Queiroz et al. / Free Radical Biology and Medicine 53 (2012) 1942–19531946in the case of multiple comparisons, with one-way ANOVA with a
Tukey posttest using the GraphPad 4.00 software. The IC50 values
were determined by ﬁtting a rectangular hyperbola to dose–
response curves using nonlinear regression.Tempol 0.4470.01 1.870.1
N3tempo 1.8170.01 1.370.1
Bztempo 2.4570.01 1.470.1
Tritempo 2.8070.02 1.570.1
a The lipophilicity coefﬁcient (log P) was determined as described under
Experimental procedures.
b The IC50 value was determined by ﬁtting a rectangular hyperbola to the
corresponding dose–response curve at 15 min as shown in Fig. 1D.Results
In vitro inhibition of MPO-mediated taurine chlorination by
nitroxides
As has been described before for tempol and other nitroxides
[9,10], N3tempo, bztempo, and tritempo (Scheme 1) inhibited
MPO-mediated taurine chlorination in a concentration- and time-
dependent manner (Fig. 1). The IC50 values determined after
15 min incubation were similar to that previously determined
for tempol (IC50 1.870.1 mM) [9,10], that is, bztempo (IC50
1.370.1 mM), N3tempo (IC50 1.470.1 mM), and tritempo (IC50
1.570.1 mM) (Table 1). The inhibitory effect of the nitroxides was
reversed by tyrosine (Supplementary Fig. S1), indicating that the
inhibitory mechanism involved accumulation of MPO-II [9,10].
The tested nitroxides are expected to have similar reduction
potential because of the common nitroxide moiety (E1
tempol¼0.84 V [44]). In contrast, their lipophilicity is expected
to differ considerably, which was conﬁrmed by the determination
of their partition coefﬁcient values, as described under Experi-
mental procedures (Table 1). Despite the differences in lipophili-
city, tempol (log P¼0.4470.01), N3tempo (log P¼1.8170.01),
bztempo (log P¼2.4570.01), and tritempo (log P¼2.7870.02)
inhibited MPO chlorinating activity with comparable IC50 values
(Fig. 1; Table 1). These results argue against a role for the
interaction of the more hydrophobic nitroxides with the aromatic
binding site in the distal MPO cavity [45] in the inhibitory
mechanism.Attenuation of carrageenan-induced edema in rat paws by nitroxides
All of the tested nitroxides (0.17 mmol/kg) signiﬁcantly
reduced carrageenan-induced paw edema (Fig. 2A). Parallel
experiments showed that the inhibitory effect of the nitroxides
was comparable to those of lower doses of classical anti-
inﬂammatory drugs, such as indomethacin and colchicine. Indeed,
indomethacin (10 mg/kg; 0.028 mmol/kg) and colchicine (2 mg/kg;
0.005 mmol/kg) inhibited paw edema by 75 and 63%, respectively,
3 h after carrageenan administration (Supplementary Fig. S2). Tem-
pol was the less efﬁcient nitroxide at early time points and its
inhibitory effect did not change much with the time elapsed after
carrageenan administration (1.5, 3.0, 4.5, or 6 h) (Fig. 2A). A similar
time proﬁle for the inhibitory effect of tempol in rat paw edema has
been previously reported [15]. At early times, the most efﬁcient
nitroxide was tritempo but its inhibitory effect decreased at longer
times, becoming similar to those of the other nitroxides 6 h after
carrageenan administration (Fig. 2A). At this time point, all of the
tested nitroxides inhibited carrageenan-induced edema by approxi-
mately 42%. In contrast, at earlier time points, there was a good
correlation between the inhibitory effect of the nitroxide and the log
Fig. 2. Inhibition of carrageenan-induced paw edema in rats by nitroxides. (A) Tempol (&), N3tempo (W), bztempo (X), tritempo (), or DMSO (J) was administered ip
15 min before intraplantar injection of carrageenan (100 ml of 1% carrageenan diluted in saline) into the left hindfoot pad. At the speciﬁed times, the paw thickness was
measured by using a vernier caliper. The values shown are the mean7standard deviation values obtained in experiments with four different animals; *p o 0.001, one-
way ANOVA with Tukey posttest for multiple comparisons. (B) The percentage of inhibition of carrageenan-induced paw edema by the tested nitroxides 3 h after
carrageenan administration plotted against the log P value of each nitroxide. (C) The percentage of inhibition of carrageenan-induced paw edema by the tested nitroxides
6 h after carrageenan administration plotted against the log P value of each nitroxide. Correlation coefﬁcients (r) were signiﬁcant at the 0.01 level (one-tailed).
(D) Representative levels of nitroxide (black bar) and nitroxide plus hydroxylamine (white bars) in the paws of rats treated with carrageenan and tempol or tritempo at the
speciﬁed times determined by EPR analysis. The inset shows a representative EPR spectrum obtained after the addition of 1 mM ferricyanide to paw homogenates of a rat
treated with tritempo 3 h after carrageenan administration. The instrumental conditions were microwave power, 10 mW; modulation amplitude, 0.1 mT; time constant,
327 ms; scan rate, 0.029 mT/s.
Fig. 3. Levels of (A) nitrated and (B) oxidized proteins in paw homogenates 6 h after carrageenan administration obtained from rats untreated or treated with nitroxides.
Homogenates (5 mg of protein) were loaded onto a nitrocellulose membrane through a dot-blot system, stained with Ponceau S, and probed with an antibody against (A) 3-
nitrotyrosine or (B) methionine sulfoxide residues, as described under Experimental procedures. Protein nitration was semiquantiﬁed by a comparison with a standard of
BSA nitrated with peroxynitrite, whereas the methionine sulfoxide content was normalized as a percentage of the carrageenan control. The insets are representative of
three independent experiments. Labeling: Car, naive; Car, carrageenan-treated animal; Ind, Car plus indomethacin; Tpl, Car plus tempol; N3t, Car þ N3tempo; Bzt, Car
plus bztempo; Tri, Car þ tritempo; Alb , 5 mg BSA; and Albþ 5 mg BSA containing 5 pmol of nitrotyrosine. The values shown are the means7standard deviation obtained
in experiments using four different animals; *p o 0.01, **p o 0.05.
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result probably arises from the fact that the absorption and trans-
port of a drug in animal models usually correlate with the log of its
partition coefﬁcient [46]. Thus, a faster absorption and transport of
tritempo could be responsible for its inhibitory effect being sig-
niﬁcantly higher than that of tempol at earlier times after carragee-
nan administration (Fig. 3A). Accordingly, EPR analysis of pawhomogenates of rats treated with tritempo and sacriﬁced 3 h after
carrageenan administration showed a higher total level of nitroxide
(nitroxide plus hydroxylamine) than that of rats treated with tempol
(approximately 4 and 2 mM, respectively; Fig. 2D). Six hours after
carrageenan administration, both nitroxides and their corresponding
hydroxylamine were barely detectable (Fig. 2D), indicating that they
were metabolized to redox-inactive products [3–6].
R.F. Queiroz et al. / Free Radical Biology and Medicine 53 (2012) 1942–19531948Attenuation of carrageenan-induced protein oxidation, protein
nitration, and MPO levels in rat paws by nitroxides
The ﬁrst group of animals was sacriﬁced 6 h after carrageenan
administration and rat paw muscle homogenates were examined for
the presence of MPO and oxidized and nitrated proteins. Dot-blot
analysis showed considerable levels of proteins containing 3-
nitrotyrosine (1.9 nmol/mg; Fig. 3A) and methionine sulfoxide resi-
dues (Fig. 3B) in the paws of animals treated with carrageenan as
expected from the elicited inﬂammatory response. All of the tested
nitroxides inhibited the levels of modiﬁed proteins by approximately
40% (on average) (Fig. 3). Similarly, all of the compounds reduced the
levels of MPO in the rat paw homogenates by approximately 50%
(Fig. 4C); the excised MPO bands shown in Fig. 4C correspond to the
bands at approximately 60 kDa. Moreover, all of the nitroxides
decreased the peroxidase and the chlorinating activity in rat paws
by approximately 50% (Fig. 4A and B). We also attempted to detect
the levels of proteins containing 3-chlorotyrosine residues in
paw homogenates by LC/ESI/MS [35]. However, the levels of
3-chlorotyrosine in paw homogenates were lower than the detection
limit of the method (100 fmol; Supplementary Fig. S3), which is
higher than that of GC/ESI/MS [33]. Taken together, these results
indicate that edema, increased levels of MPO and MPO activity, andFig. 4. Levels of (A) peroxidase activity, (B) chlorinating activity, and (C) MPO protein i
rats or rats treated with nitroxides. Analyses and quantiﬁcation were performed as des
band at approximately 60 kDa. For the quantiﬁcation of MPO levels (C), commercial hum
the anti-MPO antibody was determined to be approximately 30 ng. The values shown
animals; *p o 0.01. The inset shows a representative experiment.
Fig. 5. Levels of (A) nitrated and (B) oxidized proteins in paw homogenates obtaine
nitroxides. Homogenates (5 mg of protein) were loaded onto a nitrocellulose membrane
against (A) 3-nitrotyrosine or (B) methionine sulfoxide residues as described under Exp
standard of BSA nitrated with peroxynitrite, whereas the methionine sulfoxide conte
representative experiments. Labeling: Car, naive; Car, carrageenan-treated animal; Tp
and Albþ , 5 mg BSA containing 5 pmol of nitrotyrosine. The values shown are the m
*p o 0.01.increased levels of protein oxidation and nitration are interrelated
processes that occur in rat paws during carrageenan-induced inﬂam-
mation. Additionally, the results show that, 6 h after carrageenan
administration, all of these responses are inhibited to similar extents
by the tested nitroxides.
A correlation between the lipophilicity of the nitroxide (Table 1)
and the inhibition of rat paw edema holds at all of the time points
except for 6 h (compare Fig. 2B and C). Therefore, it was important to
compare the inhibitory effects of the nitroxides on the inﬂammatory
responses at earlier time points. To this end, we selected the
nitroxides that differ most in lipophilicity, tempol and tritempo
(Table 1), and the 3-h time point because the carrageenan-induced
paw edema apparently reaches a plateau at that time (Fig. 2A).
Apparent plateaus were also observed for the levels of nitrated
proteins (2.2 and 1.9 nmol/mg at 3 and 6 h, respectively; Figs. 3A
and 5A), the levels of MPO protein (138 and 169 ng at 3 and 6 h,
respectively; Figs. 4C and 6C), and the levels of chlorinating activity
(8.2 and 9.3 U/mg at 3 and 6 h, respectively; Figs. 4B and B). In the
case of the animals treated also with tempol or tritempo, the edema
was inhibited by 41 and 74%, respectively, 3 h after carrageenan
administration (Fig. 2A). Similarly, there were signiﬁcant differences
in the reduction of most of the monitored inﬂammatory indexes by
tempol or tritempo. The levels of 3-nitrotyrosine were inhibited by 41n paw homogenates obtained 6 h after carrageenan administration from untreated
cribed under Experimental procedures. The excised MPO bands correspond to the
an MPO (400 ng) was used as standard (inset, ﬁrst lane) and the detection limit of
are the means7standard deviation obtained in experiments with four different
d 3 h after carrageenan administration from untreated rats or rats treated with
through a dot-blot system, stained with Ponceau S, and probed with an antibody
erimental procedures. Protein nitration was semiquantiﬁed by comparison with a
nt was normalized as a percentage of the carrageenan control. The insets show
l, Car plus tempol; Tri, Car plus tritempo; Col, Car plus colchicine; Alb , 5 mg BSA;
eans7standard deviation obtained in experiments with four different animals;
Fig. 6. Levels of (A) peroxidase activity, (B) chlorinating activity, and (C) MPO protein in paw homogenates obtained 3 h after carrageenan administration from untreated
rats or rats treated with nitroxides. Analyses and quantiﬁcation were performed as described under Experimental procedures. The excised MPO bands correspond to the
band at approximately 60 kDa. For the quantiﬁcation of MPO levels (C), commercial human MPO (150 ng) was used as standard (inset, ﬁrst lane) and the detection limit of
the anti-MPO antibody was determined to be approximately 30 ng. The values shown are the means7standard deviation obtained in experiments with four different
animals; *p o 0.01, **p o 0.05. The inset shows a representative experiment.
Fig. 7. (A–C) Levels of carbonylated proteins in paw homogenates 6 and 3 h after carrageenan administration obtained from rats treated or not with nitroxides.
Carbonylated proteins as revealed by one-dimensional SDS–PAGE stained with (A) FTC and (B) Coomassie blue. For determination of the protein carbonylation,
homogenates (1 mg/ml of protein, 50 ml) were incubated with 1 mM FTC and were processed as described under Experimental procedures. The image of the ﬂuorescent
protein (A) on the gel was captured, and then, the gel was stained with Coomassie blue (B). (C) The protein carbonyl ﬂuorescence was normalized to protein content for
each lane. The values shown are the means7standard deviation for n¼3; *p o 0.01. (D) Representative portion of 2D SDS–PAGE of rat paw homogenates of control and
carrageenan-treated rats as speciﬁed. The pronounced band in the treated animals was identiﬁed as rat serum albumin by proteolysis and MS analysis, as described in
the text.
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MPO levels by 46 or 62%, respectively (Fig. 6C). Therefore, tritempo
was approximately 1.5 times more effective than tempol at inhibiting
most of the monitored inﬂammatory indicators 3 h after carrageenan
administration. Accordingly, at this time, the total concentration of
tritempo in rat paws was approximately two times that of tempol
(Fig. 2D).Attenuation of carrageenan-induced protein carbonylation and
plasma exudation in rat paws by nitroxides
The level of oxidized proteins present in rat paw as ascertained
by the relative immune-quantiﬁcation of methionine sulfoxide
residues (Figs. 3B and 5B) was the only index that deviated
considerably from the other indicators that were used to monitor
Fig. 8. Inhibition of (A) carrageenan-induced edema, (B) protein nitration, and
(C) MPO chlorinating activity in rat paws by ABAH. The MPO inhibitor ABAH
(60 mg/kg) was administered ip 15 min before intraplantar injection of carragee-
nan (100 ml of 1% carrageenan diluted in saline) in the left hindfoot pad. Three
hours after carrageenan administration, (A) paw thickness was measured and (B–
D) the animals were sacriﬁced to obtain homogenates for biochemical analysis as
described under Experimental procedures. (B) Homogenates (100 mg of protein)
were subjected to SDS–PAGE and blotted against anti-3-nitrotyrosine. Labeling:
þCardithionite, homogenate from þCar was treated with dithionite (10 mM) for
10 min before loading onto the gel; Alb , 5 mg BSA; and Albþ , 5 mg BSA
containing 5 pmol of nitrotyrosine. (C) The chlorinating activity of the homo-
genates was measured as described under Experimental procedures.
(D) Homogenates (100 mg of protein) were subjected to SDS–PAGE and blotted
against anti-MPO antibody; commercial human MPO (150 ng) was used as
standard. The values shown are the mean values obtained in experiments with
two different animals; the standard deviation was less than 10%.
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nitroxides after 3 and 6 h. Indeed, the inhibitory effects of tempol
and tritempo on the levels of methionine sulfoxide were signiﬁ-
cantly different at 6 h but were similar at 3 h, in contrast to the
trend that was observed in the other monitored indexes. This
scenario could be caused by artifacts that arise from the suscept-
ibility of methionine residues to oxidation [47], although we
added 50 mM methionine during the preparation of the homo-
genates to minimize the ex vivo oxidation. In an attempt to clarify
this point, we also monitored protein oxidation by the levels of
carbonylated proteins revealed by FTC labeling followed by SDS–
PAGE (Fig. 7A). The levels of carbonylated proteins normalized for
the total protein content increased approximately 3.5 times in
response to carrageenan and were similar 3 and 6 h after its
administration (Fig. 7C). Both tempol and tritempo inhibited
protein carbonylation to 50% 3 h after carrageenan administra-
tion, but the inhibitory effect was apparently attenuated to
approximately 28% after 6 h. Taken together, the relative quanti-
ﬁcation of the levels of oxidized proteins (Figs. 3B, 5B, and 7C)
suggests that, 3 h after carrageenan administration, oxidized
proteins are likely to start being mobilized to repair, in the case
of methionine oxidation [47,48], or to degradation, in the case of
carbonylation [49]. The variability in the levels of oxidized
proteins could also result from the considerable change in the
protein proﬁle of rat paw homogenates in response to carragee-
nan, as evidenced by the corresponding SDS–PAGE gels revealed
with Coomassie blue (Fig. 7B). In response to carrageenan, there
was a relative decrease in the protein bands in the region of 37–25
kDa and an increase in the bands in the region of 70 kDa. Because
oxidative damage to proteins depends on the protein structure and
on the attacking oxidant [34,50,51], changes in the protein proﬁle are
likely to inﬂuence the bulky parameters of protein oxidation, such as
the levels of methionine sulfoxide and protein carbonylation.
The pronounced increase in the protein band in the region of
70 kDa in rat paw homogenates in response to carrageenan
(Fig. 7B) indicated plasma exudation in rat paws, with albumin
becoming the main target for carbonylation (Fig. 7A) [52,53]. This
conclusion was conﬁrmed by comparing the 2D gels of the rat
paw homogenates obtained from controls and carrageenan-
treated animals (Fig. 7D). Collection, hydrolysis with trypsin,
and MS analysis of the pronounced protein band (approximately
70 kDa and pI 6.1) observed in homogenates from carrageenan-
treated animals conﬁrmed it as rat serum albumin (matched
peptides, 17; coverage, 24%; score, 661).Fig. 9. Inhibition of rat neutrophil chemotaxis in vitro by tempol. Peritoneal rat
neutrophils were isolated, preincubated with the speciﬁed concentrations of tempol for
30 min, and tested for chemotactic migration in micropore ﬁlter assays in response to
PMA (100 ng/ml) as described under Experimental procedures. (A) Representative
microscopic images obtained in the speciﬁed experiments at the initial ﬁeld (labeled as
0 mm) and at a longitudinal distance of 50 mm from the initial ﬁeld (labeled as
þ50 mm). (B) Net migration in response to PMA in the absence and presence of the
speciﬁed concentrations of tempol. The values shown are the mean7standard
deviation values obtained in three independent experiments; *p o 0.05, one-way
ANOVA with a Tukey posttest for multiple comparisons.Attenuation of carrageenan-induced edema, MPO activity, and
protein nitration in rat paws by ABAH
All the indexes employed to monitor inﬂammation were
attenuated by the nitroxides without apparent inhibition of the
activity of MPO (Figs. 2–7). Therefore, we considered it relevant to
compare some of the effects of the nitroxides on the acute
carrageenan-induced inﬂammation with those of a potent irre-
versible inhibitor of MPO activity, ABAH [54,55]. Recently, daily
administration of ABAH (40 mg/kg; twice daily) has been shown
to reduce the acute and chronic inﬂammation associated with
multiple sclerosis in a murine model of the disease [56]. In the
case of acute carrageenan-induced inﬂammation, one dose of ABAH
(60mg/kg) reduced edema, protein nitration, and MPO activity in rat
paws but did not affect MPO levels (Fig. 8). These results indicate that
the enzymatic activity of MPO plays a role in damaging rat paw
tissues. Additionally, the results show that nitroxides and ABAH do
not share the main action mechanism but led to similar outcomes,
attenuation of the inﬂammatory response.Inhibition of rat neutrophil chemotaxis in vitro by tempol
The nitroxides, however, acted similar to lower amounts of
colchicine (2 mg/kg; 0.005 mmol/kg) in inhibiting edema, protein
nitration and oxidation, chlorinating activity, MPO levels, and
plasma exudation (Figs. 4–7 and Supplementary Fig. S2). Because
R.F. Queiroz et al. / Free Radical Biology and Medicine 53 (2012) 1942–1953 1951colchicine is a classical inhibitor of neutrophil chemotaxis [57,58],
we examined whether tempol was able to inhibit directional
migration of rat neutrophil in vitro. Peritoneal rat neutrophils
were isolated, preincubated with various concentrations of tem-
pol for 30 min, and tested for chemotactic migration in micropore
ﬁlter assays in response to PMA (100 ng/ml) [43] as described
under Experimental procedures. The results clearly show that
tempol inhibits neutrophil migration in response to PMA in a
concentration-dependent manner (Fig. 9). The considerable basal
migration (without PMA) was expected because the neutrophils
were isolated from the peritoneum after priming with sodium
caseinate.Discussion
Tempol and other cyclic nitroxides have been shown to inhibit
the chlorinating activity of MPO and the resulting oxidative
damage to proteins in vitro and in cells [9,10]. In addition, tempol
has been shown to inhibit protein nitration promoted by MPO/
hydrogen peroxide/nitrite at acid pH in vitro [59]. Therefore, it
was important to examine whether nitroxides inhibit MPO
activity and MPO-mediated damage in vivo. To this end, we
tested the effects of tempol and three more lipophilic 4-
substituted derivatives (Scheme 1; Table 1) on the acute
carrageenan-induced inﬂammation in the rat paw. The results
showed that the tested nitroxides attenuated all of the indexes
employed to monitor inﬂammation, but no inhibition of the
activity of MPO was evident (Figs. 2–7).
In contrast, all the nitroxides inhibited the chlorinating activity
of MPO in vitro with similar IC50 values (Fig. 1; Table 1). This
result argues for the importance of the reduction potential of the
nitroxide in the inhibitory mechanism [9,10] because all of the
tested compounds have the same redox center (Fig. 1) [44]. In
vivo, the attenuation of carrageenan-induced inﬂammation
showed some correlation with the lipophilicity of the nitroxide
at early time points but the differences in the effects were small
(Figs. 2 and 5–7) compared with the differences in lipophilicity
(Table 1). Therefore, increasing the lipophilicity of the tempol
moiety did not result in a considerably greater efﬁciency in the
animal model, most probably because tempol distributes well in
organs and tissues [60] and the reduction potential, which is a
crucial factor for determining protective effects [61], was almost
unchanged. Similarly, it has been previously noted that strategies
to increase the mitochondrial accumulation of nitroxides by
binding them to moieties that enhance uptake across the mito-
chondrial membrane did not enhance their protective effects
consistently (see [60] and references therein).
The effects of the nitroxides in decreasing edema, levels of
nitrated and oxidized proteins, and levels of plasma exudation in
rat paws induced by carrageenan roughly correlated with the
levels of MPO protein, which, in turn, correlated with the levels of
MPO activity (Figs. 2–7). Because no inhibition of MPO activity
was evident, we compared the effects of the nitroxides with those
of ABAH, a potent inhibitor of MPO activity in vitro [54,55] and
in vivo [56]. ABAH reduced the MPO activity but did not affect
MPO levels in rat paws (Fig. 8). In parallel, ABAH reduced edema
and protein nitration, indicating an important role for MPO
activity in promoting oxidative damage during carrageenan-
induced inﬂammation. The nitroxides acted different from ABAH
because they reduced MPO-mediated damage by reducing MPO
levels. In fact, the nitroxides behaved similar to colchicine, a
classical inhibitor of neutrophil chemotaxis (Figs. 4–7 and
Supplementary Fig. S2) [57,58]. Neutrophil recruitment in the
inﬂammatory site can be revealed by the levels of MPO in it
[30,62], indicating that the nitroxides acted mainly by inhibitingneutrophil migration. Accordingly, exploratory experiments
showed that tempol inhibited peritoneal neutrophil migration in
response to PMA in vitro (Fig. 9).
Our results present compelling evidence for the importance of
MPO in promoting oxidative damage during carrageenan-induced
inﬂammation (Figs. 4–8). Previous studies emphasized peroxyni-
trite as the damaging agent based on the use of inhibitors of nitric
oxide synthases and the use of knockout animals for the inducible
enzyme [63,64]. However, the nitric oxide metabolite nitrite is
also required for MPO to promote protein oxidation and nitration
through its peroxidase activity [34,59,65,66]. On the other hand,
our results corroborate the view that the proinﬂammatory actions
of MPO go beyond the promotion of oxidative damage. Indeed,
MPO has been shown to display cytokine-like properties that are
independent of its catalytic oxidant activities in cell cultures and
in animal models [67,68]. By interacting with the adhesion
molecule CD11b/CD18, MPO has been shown to activate neutro-
phils [67] and to delay neutrophil apoptosis [68], contributing to
the prolongation of the inﬂammatory process.
The mechanisms by which nitroxides inhibit neutrophil che-
motaxis remain to be elucidated. It has been previously suggested
that an antioxidant, manganese porphyrin, prevented neutrophil
migration in carrageenan-induced inﬂammation in rat paws by
the inhibition of endothelial oxidant injury and the preservation
of the endothelial barrier function [69]. Similarly, the nitroxides
preserved the endothelial barrier because they inhibited plasma
exudation (Fig. 7). However, nitroxides and other antioxidants
may be acting upstream of oxidative damage because recent
studies demonstrate that reactive oxygen species are key regula-
tors of neutrophil chemotaxis [70,71]. Therefore, detailed studies
of the effects of nitroxides on the signaling cascades of neutrophil
migration will be important.Acknowledgments
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